nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of protective immunity against diphtheria in a large proportion of young adults
|
Rappuoli, R. |
|
1993 |
11 |
5 |
p. 576-577 2 p. |
artikel |
2 |
AIDS/HIV in the US military
|
Tramont, E.C. |
|
1993 |
11 |
5 |
p. 529-533 5 p. |
artikel |
3 |
Analysis of disease progression from clinical observations of US Air Force active duty members infected with the human immunodeficiency virus: distribution of AIDS survival time from interval-censored observations
|
Aragón, Jorge |
|
1993 |
11 |
5 |
p. 552-554 3 p. |
artikel |
4 |
Calendar
|
|
|
1993 |
11 |
5 |
p. 600- 1 p. |
artikel |
5 |
Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits
|
Nisini, Roberto |
|
1993 |
11 |
5 |
p. 582-586 5 p. |
artikel |
6 |
Clinical types of HBsAg-positive hepatitis
|
Nisini, Roberto |
|
1993 |
11 |
5 |
p. 511-515 5 p. |
artikel |
7 |
Communicable diseases: a major burden of morbidity and mortality
|
Torrigiani, G. |
|
1993 |
11 |
5 |
p. 570-572 3 p. |
artikel |
8 |
Cytokines as vaccine adjuvants: Interleukin 1 and its synthetic peptide 163–171
|
Tagliabue, Aldo |
|
1993 |
11 |
5 |
p. 594-595 2 p. |
artikel |
9 |
DNA sequence encoding Bordetella bronchiseptica outer membrane protein; for production of pig atrophic rhinitis recombinant vaccine
|
|
|
1993 |
11 |
5 |
p. 599- 1 p. |
artikel |
10 |
Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination
|
Biselli, R. |
|
1993 |
11 |
5 |
p. 578-581 4 p. |
artikel |
11 |
Early markers of HIV infection and subclinical disease progression
|
Dolan, M.J. |
|
1993 |
11 |
5 |
p. 548-551 4 p. |
artikel |
12 |
Estimates of human immunodeficiency virus (HIV) incidence and trends in the US Air Force
|
Warner, Ronald D. |
|
1993 |
11 |
5 |
p. 534-537 4 p. |
artikel |
13 |
Future approaches to vaccine development: Single-dose vaccines using controlled-release delivery systems
|
Aguado, M.T. |
|
1993 |
11 |
5 |
p. 596-597 2 p. |
artikel |
14 |
Hepatitis A and hepatitis B: Risks compared with other vaccine preventable diseases and immunization recommendations
|
Steffen, R. |
|
1993 |
11 |
5 |
p. 518-520 3 p. |
artikel |
15 |
HIV infection in the nineties
|
Kallings, Lars O. |
|
1993 |
11 |
5 |
p. 525-528 4 p. |
artikel |
16 |
HIV variability and perspectives for a vaccine
|
Verani, P. |
|
1993 |
11 |
5 |
p. 542-544 3 p. |
artikel |
17 |
Immunological parameters in current and former US Air Force personnel
|
Wolfe, William H. |
|
1993 |
11 |
5 |
p. 545-547 3 p. |
artikel |
18 |
Mechanisms of immune failure in burn injury
|
Sparkes, Brian G. |
|
1993 |
11 |
5 |
p. 504-510 7 p. |
artikel |
19 |
Method for feline leukaemia virus vaccination; cat leukaemia virus recombinant vaccine production by attenuation in the left long terminal repeat enhancer
|
|
|
1993 |
11 |
5 |
p. 598- 1 p. |
artikel |
20 |
72nd AMP/AGARD Symposium (Allergic, Immunological and Infectious Disease Problems in Aerospace Medicine)
|
D'Amelio, R. |
|
1993 |
11 |
5 |
p. 492-495 4 p. |
artikel |
21 |
Neuropsychiatric morbidity in early HIV disease: implications for military occupational function
|
Brown, George R. |
|
1993 |
11 |
5 |
p. 560-569 10 p. |
artikel |
22 |
New attenuated strain of type 1, 2 or 3 poliovirus; attenuation by introduction of Val-54 and Ala-114 in VP1 and Met-215 in VP2 capsid protein by site-directed mutagenesis for recombinant vaccine production
|
|
|
1993 |
11 |
5 |
p. 598- 1 p. |
artikel |
23 |
Protecting bovine host from bovine herpes virus type-1 infection; cattle herpes virus-1 gI, gIII and/or gIV epitope expression in mammal cell culture, using a vaccinia virus, SV40 virus or Rous-sarcoma virus vector for recombinant vaccine production
|
|
|
1993 |
11 |
5 |
p. 598- 1 p. |
artikel |
24 |
Proteinaceous lipid-containing particle with site-specific targeting ability; for use as a recombinant vaccine or diagnostic agent, comprising self-assembling protein, membrane-bound protein and lipid envelope; expression in mammal or insect cell culture
|
|
|
1993 |
11 |
5 |
p. 599- 1 p. |
artikel |
25 |
Recombinant anticoccidial vaccine containing novel epitopes; coccidiosis recombinant vaccine for Eimeria spp. immunoreactive peptide expression in Escherichia coli using plasmid ATCC 68537 and phage ATCC 68450 monoclonal antibody; DNA sequence
|
|
|
1993 |
11 |
5 |
p. 599- 1 p. |
artikel |
26 |
Recombinant varicella-zoster virus containing hepatitis B virus PreS2 or surface antigen gene; for use in production of multivalent recombinant vaccine
|
|
|
1993 |
11 |
5 |
p. 598- 1 p. |
artikel |
27 |
Recombinant virus vector encoding human papilloma virus protein; vaccinia virus vector with inverted sequences for homologous recombination; application in cervix carcinoma recombinant vaccine or immunotherapy agent construction
|
|
|
1993 |
11 |
5 |
p. 598- 1 p. |
artikel |
28 |
Relating cognitive function to military aviator performance in early HIV infection
|
Mapou, R.L. |
|
1993 |
11 |
5 |
p. 555-559 5 p. |
artikel |
29 |
Silent HIV infection
|
Aiuti, Fernando |
|
1993 |
11 |
5 |
p. 538-541 4 p. |
artikel |
30 |
Space flight and the immune system
|
Cogoli, A. |
|
1993 |
11 |
5 |
p. 496-503 8 p. |
artikel |
31 |
Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate
|
Bellanti, J.A. |
|
1993 |
11 |
5 |
p. 587-590 4 p. |
artikel |
32 |
Susceptibility in USAF recruits to vaccine-preventable diseases
|
Clardy, William F. |
|
1993 |
11 |
5 |
p. 573-575 3 p. |
artikel |
33 |
Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens
|
Gordon, Daniel M. |
|
1993 |
11 |
5 |
p. 591-593 3 p. |
artikel |
34 |
Vaccination against hepatitis B: the Italian strategy
|
Zanetti, A.R. |
|
1993 |
11 |
5 |
p. 521-524 4 p. |
artikel |
35 |
Vaccines and the military
|
Spier, R.E. |
|
1993 |
11 |
5 |
p. 491- 1 p. |
artikel |
36 |
Viral hepatitis in the US Air Force, 1980–1989
|
Parkinson, M.D. |
|
1993 |
11 |
5 |
p. 516-517 2 p. |
artikel |